Effects of recombinant human growth hormone on HIV-1-specific T-cell responses, thymic output and proviral DNA in patients on HAART: 48-week follow-up

por Herasimtschuk, Anna A, Westrop, Samantha J, Moyle, Graeme J, Downey, Jocelyn S, Imami, Nesrina
Publicado 2008

Impact of NRTI backbone on renal, bone and cardiovascular markers in HIV-infected individuals receiving a boosted protease inhibitor

por Barber, Tristan, Hill, Andrew, Jagjit Singh, Gurmit, Boffito, Marta, Nelson, Mark, Moyle, Graeme
Publicado 2014

Effect of hyperbilirubinaemia on neurocognitive, renal, bone and cardiovascular markers in HIV infection treated with boosted protease inhibitors

por Barber, Tristan J, Moyle, Graeme, Hill, Andrew, Jagjit Singh, Gurmit, Boffito, Marta, Nelson, Mark
Publicado 2014

1008. Disease Severity Impact on Long-Term Virologic Response to Ibalizumab in Expanded Access Protocol (TMB-311)

por Kumar, Princy, Leider, Jason, Slim, Jihad, Moyle, Graeme, Leonard, Maurice, Cash, R Brandon, Weinheimer, Steven, Mesquita, Pedro
Publicado 2020

A Randomized Comparative Trial of Continued Abacavir/Lamivudine plus Efavirenz or Replacement with Efavirenz/Emtricitabine/Tenofovir DF in Hypercholesterolemic HIV-1 Infected Indiv...

por Moyle, Graeme J., Orkin, Chloe, Fisher, Martin, Dhar, Jyoti, Anderson, Jane, Wilkins, Edmund, Ewan, Jacqueline, Ebrahimi, Ramin, Wang, Hui
Publicado 2015

An Indirect Comparison of Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate and Abacavir/Lamivudine + Dolutegravir in Initial Therapy

por M. Llibre, Josep, Raffi, François, Moyle, Graeme, Behrens, Georg, Bouee, Stephane, Reilly, Geraldine, Borg, Peter, Piontkowsky, David, Rogatto, Felipe
Publicado 2016

Correction: An Indirect Comparison of Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate and Abacavir/Lamivudine + Dolutegravir in Initial T...

por Llibre, Josep M., Raffi, François, Moyle, Graeme, Behrens, Georg, Bouee, Stephane, Reilly, Geraldine, Borg, Peter, Piontkowsky, David, Rogatto, Felipe
Publicado 2016

Atazanavir Plus Cobicistat: Week 48 and Week 144 Subgroup Analyses of a Phase 3, Randomized, Double-Blind, Active-Controlled Trial(§)

por Gallant, Joel, Moyle, Graeme, Berenguer, Juan, Shalit, Peter, Cao, Huyen, Liu, Ya-Pei, Myers, Joel, Rosenblatt, Lisa, Yang, Lingfeng, Szwarcberg, Javier
Publicado 2017

NGX-4010, a capsaicin 8% patch, for the treatment of painful HIV-associated distal sensory polyneuropathy: integrated analysis of two phase III, randomized, controlled trials

por Brown, Stephen, Simpson, David M, Moyle, Graeme, Brew, Bruce J, Schifitto, Giovanni, Larbalestier, Nicholas, Orkin, Chloe, Fisher, Martin, Vanhove, Geertrui F, Tobias, Jeffrey K
Publicado 2013

Switching from ritonavir to cobicistat in HIV patients with renal impairment who are virologically suppressed on a protease inhibitor

por Fisher, Martin, McDonald, Cheryl, Moyle, Graeme, Martorell, Claudia, Ramgopal, Moti, Laplante, Francois, Curley, Joanne, Graham, Hiba, Tran-Muchowski, Cecilia, Liu, Yapei, Rhee, Martin, Szwarcberg, Javier
Publicado 2014

LB-7. Weight Change in Suppressed People with HIV (PWH) Switched from Either Tenofovir Disoproxil Fumarate (TDF) or Abacavir (ABC) to Tenofovir Alafenamide (TAF)

por Sax, Paul, Althoff, Keri N, Althoff, Keri N, Brown, Todd T, Radtchenko, Janna, Diaz Cuervo, Helena, Diaz Cuervo, Helena, Ramgopal, Moti, Santiago, Steven, Moyle, Graeme, Mounzer, Karam, Elion, Richard
Publicado 2020

550. Adherence and Persistency With Modern Single vs. Multi-Tablet Antiretroviral (ARV) Regimens in First Treatment of HIV in Clinical Practice

por Mills, Anthony, Priest, Julie, Musallam, Alexander, Althoff, Keri, Eron, Joseph, Huhn, Greg, Jayaweera, Dushyantha, Mounzer, Karam, Moyle, Graeme, Mrus, Joe, Rampogal, Moti, Santiago, Steven, Sax, Paul, Voskuhl, Gene, Oglesby, Alan, Elion, Richard
Publicado 2018

Real-world efficacy of direct acting antiviral therapies in patients with HIV/HCV

por Patel, Sonia Vibhakar, Jayaweera, Dushyantha T., Althoff, Keri N., Eron, Joseph J., Radtchenko, Janna, Mills, Anthony, Moyle, Graeme, Santiago, Steven, Sax, Paul E., Gillman, Jason, Mounzer, Karam, Elion, Richard A., Huhn, Gregory D.
Publicado 2020

Antifibrotic Effects of the Dual CCR2/CCR5 Antagonist Cenicriviroc in Animal Models of Liver and Kidney Fibrosis

por Lefebvre, Eric, Moyle, Graeme, Reshef, Ran, Richman, Lee P., Thompson, Melanie, Hong, Feng, Chou, Hsin-l, Hashiguchi, Taishi, Plato, Craig, Poulin, Dominic, Richards, Toni, Yoneyama, Hiroyuki, Jenkins, Helen, Wolfgang, Grushenka, Friedman, Scott L.
Publicado 2016

Safety and Immunogenicity of an Adjuvanted Herpes Zoster Subunit Candidate Vaccine in HIV-Infected Adults: A Phase 1/2a Randomized, Placebo-Controlled Study

por Berkowitz, Elchonon M., Moyle, Graeme, Stellbrink, Hans-Jürgen, Schürmann, Dirk, Kegg, Stephen, Stoll, Matthias, El Idrissi, Mohamed, Oostvogels, Lidia, Heineman, Thomas C., Brockmeyer, Norbert, deJesus, Edwin, Esser, Stefan, Hawkins, Trevor, Lalezari, Jacob, Orkin, Chloe, Schneider, Stefan
Publicado 2015

Switching from a ritonavir-boosted protease inhibitor to a dolutegravir-based regimen for maintenance of HIV viral suppression in patients with high cardiovascular risk

por Gatell, José M., Assoumou, Lambert, Moyle, Graeme, Waters, Laura, Johnson, Margaret, Domingo, Pere, Fox, Julie, Martinez, Esteban, Stellbrink, Hans–Jürgen, Guaraldi, Giovanni, Masia, Mar, Gompels, Mark, De Wit, Stephane, Florence, Eric, Esser, Stefan, Raffi, François, Pozniak, Anton L.
Publicado 2017